126 related articles for article (PubMed ID: 3153712)
1. Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach.
Bertolino A; Crippa D; di Dio S; Fichte K; Musmeci G; Porro V; Rapisarda V; Sastre-y-Hernández M; Schratzer M
Int Clin Psychopharmacol; 1988 Jul; 3(3):245-53. PubMed ID: 3153712
[TBL] [Abstract][Full Text] [Related]
2. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
Hebenstreit GF; Fellerer K; Fichte K; Fischer G; Geyer N; Meya U; Sastre-y-Hernández M; Schöny W; Schratzer M; Soukop W
Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
[TBL] [Abstract][Full Text] [Related]
3. Is phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind double-dummy study between rolipram and desipramine in hospitalized major and/or endogenous depressives.
Bobon D; Breulet M; Gerard-Vandenhove MA; Guiot-Goffioul F; Plomteux G; Sastre-y-Hernández M; Schratzer M; Troisfontaines B; von Frenckell R; Wachtel H
Eur Arch Psychiatry Neurol Sci; 1988; 238(1):2-6. PubMed ID: 3063534
[TBL] [Abstract][Full Text] [Related]
4. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
Bohacek N; Ravic M; Bizière K
Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
[TBL] [Abstract][Full Text] [Related]
5. In-patient major depression: is rolipram as effective as amitriptyline?
Scott AI; Perini AF; Shering PA; Whalley LJ
Eur J Clin Pharmacol; 1991; 40(2):127-9. PubMed ID: 2065693
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary results of a double-blind study between rolipram and desipramine in hospitalized patients with major depressive symptoms].
Guiot-Goffioul F; Gerard-Vandenhove MA; Troisfontaines B; Breulet M; von Frenckell R; Bobon D
Acta Psychiatr Belg; 1987; 87(2):230-5. PubMed ID: 3618273
[TBL] [Abstract][Full Text] [Related]
7. A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder.
Fleischhacker WW; Hinterhuber H; Bauer H; Pflug B; Berner P; Simhandl C; Wolf R; Gerlach W; Jaklitsch H; Sastre-y-Hernández M
Neuropsychobiology; 1992; 26(1-2):59-64. PubMed ID: 1475038
[TBL] [Abstract][Full Text] [Related]
8. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics.
Magni G; Garreau M; Orofiamma B; Palminteri R
Neuropsychobiology; 1989; 20(3):126-31. PubMed ID: 2668780
[TBL] [Abstract][Full Text] [Related]
9. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.
Amsterdam JD; Kaplan M; Potter L; Bloom L; Rickels K
Psychopharmacology (Berl); 1986; 88(4):484-8. PubMed ID: 3085137
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner JP; Boyer WF
Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
[TBL] [Abstract][Full Text] [Related]
11. Fluvoxamine and imipramine: results of a long-term controlled trial.
Guelfi JD; Dreyfus JF; Pichot P
Int Clin Psychopharmacol; 1987 Apr; 2(2):103-9. PubMed ID: 3110264
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
[TBL] [Abstract][Full Text] [Related]
13. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
Psychopharmacol Bull; 1989; 25(2):267-71. PubMed ID: 2532373
[No Abstract] [Full Text] [Related]
14. Clinical and biochemical effects of the selective phosphodiesterase inhibitor rolipram in depressed inpatients controlled by determination of plasma level.
Laux G; Becker T; Kühne G; Lesch KP; Riederer P; Beckmann H
Pharmacopsychiatry; 1988 Nov; 21(6):378-9. PubMed ID: 3244773
[No Abstract] [Full Text] [Related]
15. A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients.
Arminen SL; Ikonen U; Pulkkinen P; Leinonen E; Mahlanen A; Koponen H; Kourula K; Ryyppö J; Korpela V; Lehtonen ML
Acta Psychiatr Scand; 1994 Jun; 89(6):382-9. PubMed ID: 8085467
[TBL] [Abstract][Full Text] [Related]
16. Results of a phase II study of the antidepressant effect of rolipram.
Zeller E; Stief HJ; Pflug B; Sastre-y-Hernández M
Pharmacopsychiatry; 1984 Nov; 17(6):188-90. PubMed ID: 6393150
[TBL] [Abstract][Full Text] [Related]
17. [Onset of the antidepressive effect of rolipram, an antidepressant with a new mechanism of action, in comparison with imipramine].
Meya U; Fichte K
Nervenarzt; 1991 May; 62(5):288-91. PubMed ID: 1865959
[No Abstract] [Full Text] [Related]
18. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
Feiger AD
Psychopharmacol Bull; 1996; 32(4):659-65. PubMed ID: 8993088
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of new generation antidepressants: meta-analysis of imipramine-controlled studies.
Möller HJ; Fuger J; Kasper S
Pharmacopsychiatry; 1994 Nov; 27(6):215-23. PubMed ID: 7870742
[TBL] [Abstract][Full Text] [Related]
20. Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders.
Salzmann E; Robin JL
Neuropsychobiology; 1995; 31(2):68-75. PubMed ID: 7760988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
